568 The BET bromodomain inhibitor OTX015 shows synergy with several anticancer agents in preclinical models of mantle cell lymphoma (MCL) and multiple myeloma (MM)
Bernasconi, E., Tarantelli, C., Gaudio, E., Kwee, I., Stathis, A., Riveiro, E., Herait, P., Cvitkovic, E., Zucca, E., Bertoni, F.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70694-X
Date:
November, 2014
File:
PDF, 56 KB
english, 2014